Posts by

Karen Kathan

Home / Blog Archive

CALL FOR APPLICATIONS: EDITOR-IN-CHIEF, Pain Medicine

The American Academy of Pain Medicine (AAPM) announces the search for Editor-in-Chief (EIC) of its journal, Pain Medicine, published by Oxford University Press.

Scope

Pain Medicine is unique amongst dedicated pain journals because it has always emphasized the need to represent the breadth of scholarship in clinical and translational pain research.It has always published what is relevant to the field, and, as a result, it is the only pain journal with dedicated sections for each of the major areas in our field. Pain Medicine is a forum for empirical findings, systematic reviews, and conceptual papers. The EIC is expected to be a recognized national or international leader in our specialty, with a scholarly track record and a record of high-level performance in previous journal activities either within or outside the specialty of pain medicine. The EIC position is estimated to require 20 hours per week, or approximately 40% professional effort, with anticipated effort being distributed 5 days a week.Duties will include managing the virtual editorial office, senior associate editors, section editors, and the relationship with our publisher, Oxford University Press. The Editor-in-Chief will receive an annual salary + an incentive component based on journal performance. The EIC will also participate as an ex officio member of the AAPM Executive Committee.

Applications

Interested individuals should submit their CV and a brief cover letter conveying why they are interested in the position and the strengths of their skill set they would bring to the journal.

We are requesting these materials by Monday, December 7th at the latest. An AAPM task force will review all applications and discuss next steps with each candidate.

Please submit your application to Phil Saigh, AAPM Executive Director, at [email protected]

Sincerely,

Ajay D. Wasan, MD MSc

President, AAPM

ICD-10 Changes for 2021

The ICD-10-CM update for 2021 became effective on October 1, 2020. The 2021 edition contains 72,616 codes that includes 490 additions, 47 code revisions and 58 deletions. There are also 162 new headers along with 7 deletions and 5 revisions. The ICD-CM code set in the United States is maintained by the ICD Coordination and Maintenance Committee. This committee includes representatives from the National Center for Health Statistics (NCHS) and the Centers for Medicare and Medicaid Services (CMS). This committee reviews all requests for changes or additions to the code set. The Director of NCHS and the Administrator of CMS make the final coding data set decisions.

New codes were added in Chapter 6 (Diseases of the Nervous System (G00-G99)) and Chapter 13 (Diseases of the Musculoskeletal System and Connective Tissue (M00-M99)). Both chapters have revisions to inclusion codes, terminology and instructions. Although the codes will appear in your EHR, the changes in terms and instructions likely will not appear in your EHR code selection process. However, a digital copy of the ICD manual is available in most EHR systems.

The subcategory G96.0 (Cerebral spinal fluid leak) has been expanded to include the following new codes:

  • G96.00 Cerebrospinal fluid leak, unspecified
  • G96.01 Cranial cerebrospinal fluid leak, spontaneous
  • G96.02 Spinal cerebrospinal fluid leak, spontaneous
  • G96.08 Other cranial cerebrospinal fluid leak
  • G96.09 Other spinal cerebrospinal fluid leak

Additional codes were added to select subcategories in the following categories to indicate “other specified site”.

  • M05 Rheumatoid arthritis with rheumatoid factor
  • M06 ChangeM06 Other rheumatoid arthritis
  • M08 ChangeM08 Juvenile arthritis
  • M19 Other and unspecified osteoarthritis
  • M24 Other specific joint derangements
  • M25 Other joint disorder, not elsewhere classified

Two new subcategories were added to M26.6 (Temporomandibular joint disorders) and both include options for laterality. The new subcategories are:

  • M26.64 Arthritis of temporomandibular joint
  • M26.65 Arthropathy of temporomandibular joint​

Other ICD Chapters also contain changes. Those of most interest to Pain Management Physicians are noted here. ICD code R51 (Headache) was deleted in Chapter 18 (Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified) and replaced with two new codes:

  • R51.0 Headache with orthostatic component, not elsewhere classified
  • R51.9 Headache, unspecified

Changes in Chapter 19 (Injury, poisoning and certain other consequences of external causes) includes the addition of new codes and subcategories under T40.4 (Poisoning by, adverse effect of and underdosing of other synthetic narcotic). The new subcategories are T40.41 (fentanyl or fentanyl analogs) and T40.42 (tramadol). Each contains new codes that match the current code distinctions found within T40.4.

Multiple new codes were added to Chapter 5 (Mental, behavioral and neurodevelopmental disorders) related to substance abuse disorders. The changes primarily add new subcategories and codes related to withdrawal. Codes in categories F10 (Alcohol related disorders), F13 (Sedative, hypnotic, or anxiolytic related disorders) and F19 (Other psychoactive substance related disorders) have a 6th characters describing manifestations of withdrawal.

The new codes and instructions are effective October 1, 2020 through September 30, 2021.

American Academy of Pain Medicine Rejects “Fake News”

The American Academy of Pain Medicine stands by our colleagues in the AMA to condemn the statements by President Trump referenced in a recent New York Times article, regarding accusations of profit and self-interest in taking care of patients during the pandemic. Physicians have put themselves and their families at risk in executing their Hippocratic oath to treat patients despite the personal risks. In addition to balancing the treatment of acute and chronic pain with the need to keep our patients safe from COVID, a majority of our members are anesthesiologists, many of whom are working in hospitals to take care of the critically ill as well. At AAPM we support our members’ selfless dedication to our patients, despite the risks of personal harm.

AMA Releases New Code for Use During the Public Health Emergency

On September 8, the American Medical Association (AMA) released a new code to report the additional practice expenses incurred during a public health emergency (PHE) that is over and above those usually included in a medical visit or service. The code accounts for the additional supplies, materials, and clinical staff time associated with evaluation, management and procedural services provided during the current PHE. 

 Code 99072 is effective immediately and reads:

Additional supplies, materials, and preparation time required and provided by the physician or other qualified health care professional and/or clinical staff over and above those usually included in an office visit or other service(s), when performed during a nationally declared public health emergency due to respiratory transmitted infectious disease.

This new code is intended to capture the following practice expense activities:

  • Time over what is included in the primary service of clinical staff time (registered nurse [RN]/ licensed practical nurse [LPN]/ medical technical assistant [MTA]) to conduct a pre-visit phone call to screen the patient (symptom check), provide instructions on social distancing during the visit, check patients for symptoms upon arrival, apply and remove PPE, and perform additional cleaning of the examination/procedure/imaging rooms, equipment, and supplies
  • Three surgical masks
  • Cleaning supplies, including additional quantities of hand sanitizer and disinfecting wipes, sprays, and cleansers

The code should only be reported when the service is rendered in a non-facility place of service (POS) setting, such as a physician office, and in an area where the activities are required to lessen the transmission of the respiratory disease. The code should be reported only during a PHE due to a respiratory disease and only for additional items required to provide a safe in-person service. The code is to be reported once per in-person patient encounter regardless of the number of services provided at that encounter.

Currently, there are no relative value units (RVU) assigned to the code. The AMA has sent a request to the Centers for Medicare and Medicaid Services (CMS) to immediately implement the code and to assign practice expense RVUs based on input provided by the AMA. Practices can choose to assign a charge and submit the code to third-party payers however individual payer policies will dictate how the claim will be processed.

A special edition CPT Assistant article addressing this code and an additional COVID related laboratory code can be accessed here

New Look for the AAPM E-News

AAPM is excited to announce that we have partnered with MultiView, to produce our email newsletter, AAPM E-News. We know how important it is to have direct access to the latest information, trends, and developments in our ever-changing field of pain medicine. This customized news brief will continue to offer AAPM members a hand-curated selection of relevant news and association updates relevant to AAPM members. We will work with a dedicated MultiView news editor to create a weekly newsletter to ensure that stories in AAPM E-News are timely and interesting — that there is always something new and exciting in your inbox.

If you’re already a member of AAPM, be on the lookout for AAPM E-News in your inbox every week, beginning Wednesday September 30, 2020. Not a member? Visit the AAPM website for more information on membership. 

CMS Releases Proposed Rule for 2021 Physician Fee Schedule

On August 3, 2020, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes proposals to update payment policies and payment rates for services furnished under the Medicare Physician Fee Schedule (PFS) on or after January 1, 2021. While the proposed rule predicts an almost 11% overall reduction in payments, the impact will not affect all physicians and specialties in the same manner. In fact, pain management specialists may realize a 7% increase overall in Medicare payments.

The Basis for the Change in Payment

The Social Security Act, that established Medicare, requires that increases or decreases in relative value units (RVUs) may not cause the amount of expenditures for the year to differ by more than $20 million from what it would have been in the absence of any changes. If the threshold is exceeded, adjustments are made to the dollar conversion factor (CF) to maintain budget neutrality.

For 2021, the primary reason for the adjustments is due to significant increases in the RVUs for the revised Office/Outpatient Evaluation and Management (E/M) services (99202-99215). The proposed rule confirms CMS’s intention to implement these new codes and finalize guidelines and payment rates. The increases are based on recommendations on resource costs from the AMA/Specialty Society RVS Update Committee (RUC), which AAPM participates in and advocates on behalf of its members. Since office/outpatient E/M services account for ~20% of overall expenditures, an increase in the value for these codes makes a substantial impact on the fee schedule. As a result, the proposed rule estimates a conversion factor (CF) of $32.26 which is a $3.83 reduction from the 2020 CF of $36.09.

As a result, pain specialists who provide multimodal care, including a mix of initial and follow up evaluations in addition to the procedures they perform, are likely to see greater reimbursement for the E/M visits and greater overall practice revenue. Nevertheless, despite CMS’ goal of reducing reimbursements for procedures, the AAPM representatives working with RUC will continue to fight for appropriate procedure reimbursement and challenge any and all attempts to reduce these payments in our specialty. 

Impact on Physicians and Specialties

The payment impacts in the proposed rule reflect averages by specialty based on Medicare utilization and classifications. Specialties with a greater proportion of E/M services may see increases in payments while those specialties that are primarily procedural-based may see decreases.

AAPM President Ajay D. Wasan, MD MSc, commented, “For some time, CMS policies and reimbursement decisions have effectively shifted reimbursement from procedures toward more comprehensive care-based services such as E/M services. This is reflected in the current plan to not apply the E/M increases to those E/M services included in surgical procedures with a 10 and 90-day global period. In other words, pain specialists who practice multimodal care and integrate the use of procedures, medications, physical therapy, and other modalities are likely to see an increase in practice revenue from their E/M services. These changes will encourage physicians to review treatment plans, establish long term goals, and focus more on patient engagement.”

Although pain medicine physicians do perform procedures, office visits comprise a significant portion of the typical services offered by comprehensive pain medicine practices. Therefore, the predicted average for pain medicine specialties reflect an increase in Medicare payments. The payment impact for an individual physician could vary from the average and would depend on the mix of services he or she furnishes.

Dr. Wasan continued, “The current trend by pain medicine specialists to offer multimodal services with an appropriate mix of E/M services not only improves patient care, it also supports the financial health of physician practices.”

Budget Neutrality and the Public Health Emergency

The AMA and many specialty societies had proposed to CMS that the budget neutrality adjustment should be waived considering the COVID-19 public health emergency. While the proposed rule did not accept that recommendation, comments on the proposed rule will be accepted until October 5, 2020. In the absence of positive action by CMS, Congress can waive the budget neutrality payment reductions. Historically, Congress has eliminated reductions in physician payments based on the prior formula for neutrality adjustments known as the Sustainable Growth Rate (SGR).

AAPM leadership and staff will continue to review possible actions in collaboration with the AMA and other specialties societies to reduce the financial hardship on physicians imposed by the negative change to the dollar conversion factor.

View text of the proposed rule

Access the CMS fact sheet to learn more. 

FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing

FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information. This will help ensure that health care professionals discuss the availability of naloxone and assess each patient’s need for a naloxone prescription when opioid pain relievers or medicines to treat OUD are being prescribed or renewed. The patient Medication Guides will also be updated. Full story.

Congratulations to Inaugural AAPM Early Investigator Research Grant Recipient, Ben Alter, MD PhD

June 17, 2020, CHICAGO –   The AAPM Early Investigator Research Grant was created in partnership with US WorldMeds to support preliminary or pilot research projects relevant to a comprehensive, multidisciplinary, patient-centered approach to pain management. AAPM members who are early stage investigators were invited to submit proposals for the opportunity to receive a $15,000 one-year grant.

AAPM is pleased to announce Ben Alter, MD PhD as the recipient of AAPM’s inaugural Early Investigator Research Grant. The grant will support Dr. Alter’s research entitled Brain biomarker of endogenous analgesia in patients with chronic knee pain. Dr. Alter is an Assistant Professor and the Director for Translational Pain Research in the Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh. After studying medicine and neuroscience at Washington University, he completed training in anesthesiology at University of California, San Francisco and pain medicine at the University of Pittsburgh. 

Dr. Alter’s research explores how the brain modulates pain and how endogenous pain dampening systems can be systematically leveraged for novel pain therapies. The objective of his AAPM Research Grant-funded study is to assess whether functional near-infrared spectroscopy (fNIRS) can be used to detect changes in cortical activity during endogenous analgesia in patients with chronic knee pain from osteoarthritis. Using this alternative brain imaging technique will enable hemodynamic changes in the cerebral cortex to be measured by recording low-intensity infrared light absorption by hemoglobin over time. fNIRS is portable, scalable, can be collected in the ambulatory setting, and does not require supine positioning.

According to Dr. Alter, recent evidence suggests that endogenous analgesia is diminished in chronic pain states. Interestingly, the brain circuitry implicated in endogenous analgesia also appears to change in chronic pain states, as measured by functional magnetic resonance imaging (fMRI) techniques. As such, both psychophysical tests thought to reflect endogenous analgesia and fMRI measures are potential chronic pain biomarkers. However, the relative importance of these changes to the pathophysiology of chronic pain remains unknown, partly due to a lack of prospective studies in patients in relation to their course of chronic pain. Major barriers to these studies are the cost and patient tolerability of repeated fMRI sessions.

Research shows that mechanistically relevant biomarkers may allow for personalization of chronic pain management. It is hoped that Dr. Alter’s research will lead to the discovery of the brain biomarker of endogenous analgesia in patients with chronic knee pain.

“I am honored to be selected for this grant. This pilot grant will jump start promising research that I hope will improve pain care for patients dealing with chronic pain. It was truly made possible with the mentorship and support of my friends and colleagues at Pitt and beyond,” commented Dr. Alter. AAPM wishes him and his team the best as they utilize this early investigator grant.

About AAPM

The American Academy of Pain Medicine is the premier medical association for pain physicians and their treatment teams with some 2,000 members. Now in its 37th year of service, the Academy’s mission is to advance and promote the full spectrum of multidisciplinary pain care, education, advocacy, and research to improve function and quality of life for people in pain. Information is available on the Academy’s website at painmed.org

CMS Issues Summary of Physician Fee Schedule Policies During the Public Health Emergency (PHE)

The Centers for Medicare and Medicaid Services (CMS) has issued a Medicare Learning Network (MLN) article with an effective date of June 12, 2020. The article summarizes the policy changes impacting the Physician Fee Schedule during the time of this Public Health Emergency (PHE). During the early part of the PHE, numerous changes were made to reimbursement policies associated with telehealth and non-face-to-face services. The article addresses the cumulative changes that occurred over this period. Specifically, the following topics are addressed:

  • Expansion of telehealth services to include certain hospital-based services
  • Outlines the change in requirements for telehealth modalities
  • Expansion of virtual check-in services to new and established patients
  • Direct supervision requirements for services provided by clinical staff
  • Reimbursement of telephone services and expansion of codes to both new and established patients
  • Documentation, code selection and reimbursement of E/M services during the PHE
  • Changes to supervision requirements for diagnostic tests
  • Application of Teaching Physician requirements for residents and expansion of therapy services provided by students
  • Flexibilities for Opioid Treatment Programs to use interactive technology for counseling, therapy and assessments
  • Guidelines for ordering COVID-19 testing

​ The article can be accessed here.

1 2 3 26 27
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound
Pain Medicine Journal
Access to this page is restricted to members only! Not a mamber? Join Now!

Ask Us Anything. Anytime.

📝 Fill in your details and we’ll get back to you in no time.
AAPM

American Academy of Pain Medicine